Tag: NASDAQ:TLGT

December 14, 2018

Teligent Executes $120 Million Financing Agreement

Teligent (NASDAQ:TLGT) announced today that on December 13, 2018 the Company entered into a definitive first lien revolving credit agreement with...
October 24, 2018

Teligent Announces FDA Approval of Desoximetasone Ointment USP 0.05%

Teligent (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new...
October 17, 2018

Teligent Announces FDA Approval of Fluocinonide Cream USP, 0.05%

Teligent (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new...
October 2, 2018

Teligent Announces FDA Approval of Fluocinonide Ointment USP, 0.05%

Teligent (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new...
June 13, 2018

Teligent Announces FDA Approval of Diflorasone Diacetate Ointment 0.05%

Teligent (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new...